Help prioritise diabetes and pregnancy research | University of Oxford

Help prioritise diabetes and pregnancy research

2 July 2019

Women, their families, and healthcare professionals are invited to help prioritise research that will benefit women and families affected by diabetes and pregnancy.

Diabetes affects around 38,000 women giving birth in the UK (5%) and rates are increasing. Although most women have healthy babies, diabetes can increase the risk of complications such as pre-term birth, and long-term risks such as cardiovascular disease in mothers and babies.

However, many women report a lack of information relating to diabetes and pregnancy, and many questions remain unanswered by research. A new project, led by the University of Oxford, will identify the areas of research that are most important to the people concerned by diabetes before, during and after pregnancy.

Project co-lead, Dr Goher Ayman, from the National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, said ‘More research is needed to help provide the best healthcare for women with or at risk of diabetes, who are planning pregnancy or are pregnant.

‘We want to work with women, their support networks, and healthcare professionals to identify uncertainties about the prevention, diagnosis, treatment, and health impacts of pregnancy with diabetes of any type. We are currently inviting people to tell us their questions about diabetes and pregnancy by completing our survey. Their questions will be used to produce a shortlist of priority research topics.’
The project will follow an established process developed by the James Lind Alliance, an initiative that aims to help direct research funding towards the issues that matter most to patients and clinicians.

Over about 18 months, the project team will work with women, their families and healthcare professionals to identify where little is known, or where there are uncertainties about, healthcare and wellbeing in diabetes and pregnancy. Those involved will agree a top ten list of priority research questions which will be shared with funders of health research. 

Karen Addington, UK Chief Executive of the type 1 diabetes charity JDRF, said ‘This is a superb opportunity for women living with type 1 diabetes to help shape diabetes research, via their own insights and experiences. We need the outcomes that matter to them to be increasingly at the heart of research design.’

Sonya Carnell was diagnosed with type 2 diabetes after the birth of her first child and had diabetes during her second pregnancy. She said ‘Despite having a family history of diabetes, I wasn’t aware of the risks relating to diabetes and pregnancy. Once I had been diagnosed, I read a lot about it and asked lots of questions, but I still found that there was a lack of information. I hope that by involving those with direct experience of the issue, this project will help to direct funding to the unanswered questions that affect me and many other women.’ 

To find out more or participate in the project, please visit https://www.npeu.ox.ac.uk/jla-psp. The project team are looking for input from those affected by all types of diabetes, including pregnancy with pre-existing diabetes, and gestational diabetes which develops during pregnancy.

The project is funded by the University of Oxford John Fell Fund, the Nuffield Department of Population Health, and the Diabetes Research & Wellness Foundation. Project partners are: the Diabetes Research & Wellness Foundation, Diabetes UK, the James Lind Alliance, JDRF the type 1 diabetes charity, the Oxford Biomedical Research Centre, and the Oxford Centre for Diabetes, Endocrinology and Metabolism.

Further information: For further information or interviews, please contact:

Chris McIntyre, (T): +44 (0)1865 270 046, (E) christopher.mcintyre@admin.ox.ac.uk
Anne Whitehouse, (T): +44 (0)1865 289474, (E) anne.whitehouse@ndph.ox.ac.uk

Project leaders:
Dr Goher Ayman
(T) 01865 289757, (E) goher.ayman@npeu.ox.ac.uk 
Prof Marian Knight 
(T) +44 1865 289727, (E) marian.knight@npeu.ox.ac.uk 

Notes to editors

Please see below for two case studies.

The Nuffield Department of Population Health (NDPH) is a world-leading research institute, based at the University of Oxford, which investigates the causes and prevention of disease. NDPH has over 500 staff working in several world-leading research groups, including the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), the Cancer Epidemiology Unit (CEU), the National Perinatal Epidemiology Unit (NPEU) and other groups working on public health, health economics, ethics and health record linkage. It is also a key partner in the new Oxford University Big Data Institute. ndph.ox.ac.uk

The National Perinatal Epidemiology Unit (NPEU) is a multi-disciplinary research unit which conducts methodologically rigorous research to provide evidence to improve the care and outcomes for women, babies and their families during pregnancy, childbirth, the newborn period and early childhood, as well as promoting the effective use of resources by perinatal health services. The unit runs randomised controlled trials, national surveillance programmes and surveys, confidential enquiries, aetiological studies and a disease register. The results of its research sit at the nexus of public and population health sciences, clinical care and health policy development. The Unit was established at the University of Oxford in 1978. npeu.ox.ac.uk.

About JDRF

  • JDRF is the leading global organisation funding type 1 diabetes research. Our mission is to accelerate life-changing breakthroughs to treat and cure type 1 diabetes 
  • Our volunteers around the globe are dedicated to campaigning for our vision of a world without type 1 diabetes. Together we raise funds, awareness and understanding
  • We will find the cure for type 1 diabetes. It’s simply a question of time, money and great research
  • For more information, please visit jdrf.org.uk or follow us on Twitter: @JDRFUK